These benefits, along with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two aid the concept of targeting ACKR3 as a novel approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Conditions. Distributing this review implies that https://katew469dnk9.wikicorrespondence.com/user